However, given the recurring themes that loss of ARID1A in epithelial or hematopoietic cells can be a step toward cancer transformation, these new findings do raise an interesting question of whether targeting ARID1A may increase the transformative potential of T cell to acquire additional cancer characteristics. The gene discussed is ARID1A; the disease is cancer.